126 related articles for article (PubMed ID: 28842253)
41. Estrogen receptors: role in breast cancer.
Duffy MJ
Crit Rev Clin Lab Sci; 2006; 43(4):325-47. PubMed ID: 16769596
[TBL] [Abstract][Full Text] [Related]
42. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.
Hole S; Pedersen AM; Hansen SK; Lundqvist J; Yde CW; Lykkesfeldt AE
Int J Oncol; 2015 Apr; 46(4):1481-90. PubMed ID: 25625755
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
Smollich M; Götte M; Fischgräbe J; Radke I; Kiesel L; Wülfing P
Anticancer Res; 2009 Jun; 29(6):2167-71. PubMed ID: 19528477
[TBL] [Abstract][Full Text] [Related]
44. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
45. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
46. ERα directly activated the MDR1 transcription to increase paclitaxel-resistance of ERα-positive breast cancer cells in vitro and in vivo.
Shi JF; Yang N; Ding HJ; Zhang JX; Hu ML; Leng Y; Han X; Sun YJ
Int J Biochem Cell Biol; 2014 Aug; 53():35-45. PubMed ID: 24786296
[TBL] [Abstract][Full Text] [Related]
47. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
Zhang X; Zhang B; Zhang P; Lian L; Li L; Qiu Z; Qian K; Chen A; Liu Q; Jiang Y; Cui J; Qi B
PLoS One; 2019; 14(5):e0217181. PubMed ID: 31120927
[TBL] [Abstract][Full Text] [Related]
48. Neuroglobin overexpression induced by the 17β-Estradiol-Estrogen receptor-α Pathway reduces the sensitivity of MCF-7 Breast cancer cell to paclitaxel.
Fiocchetti M; Cipolletti M; Leone S; Ascenzi P; Marino M
IUBMB Life; 2016 Aug; 68(8):645-51. PubMed ID: 27312786
[TBL] [Abstract][Full Text] [Related]
49. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.
Aguilar H; Solé X; Bonifaci N; Serra-Musach J; Islam A; López-Bigas N; Méndez-Pertuz M; Beijersbergen RL; Lázaro C; Urruticoechea A; Pujana MA
Oncogene; 2010 Nov; 29(45):6071-83. PubMed ID: 20711236
[TBL] [Abstract][Full Text] [Related]
50. Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology.
Li K; Kang H; Wang Y; Hai T; Rong G; Sun H
Med Oncol; 2016 Jul; 33(7):64. PubMed ID: 27235140
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα.
Ding J; Wang X; Zhang Y; Sang X; Yi J; Liu C; Liu Z; Wang M; Zhang N; Xue Y; Shen L; Zhao W; Luo F; Liu P; Cheng H
Cancer Lett; 2019 Jan; 440-441():54-63. PubMed ID: 30315845
[TBL] [Abstract][Full Text] [Related]
52. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
[TBL] [Abstract][Full Text] [Related]
53. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
54. Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.
Zhao Y; Zhao C; Lu J; Wu J; Li C; Hu Z; Tian W; Yang L; Xiang J; Zhou H; Deng Z; Huang J; Hong K
Pharmacol Res; 2019 Aug; 146():104294. PubMed ID: 31175940
[TBL] [Abstract][Full Text] [Related]
55. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
56. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor α roles in breast cancer chemoresistance.
Xu CY; Jiang ZN; Zhou Y; Li JJ; Huang LM
Asian Pac J Cancer Prev; 2013; 14(7):4049-52. PubMed ID: 23991950
[TBL] [Abstract][Full Text] [Related]
58. The effect of letrozole with misoprostol for medical termination of pregnancy on the expression of steroid receptors in the placenta.
Lee VC; Gao J; Lee KF; Ng EH; Yeung WS; Ho PC
Hum Reprod; 2013 Nov; 28(11):2912-9. PubMed ID: 23980056
[TBL] [Abstract][Full Text] [Related]
59. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.
Chen XS; Wang KS; Guo W; Li LY; Yu P; Sun XY; Wang HY; Guan YD; Tao YG; Ding BN; Yin MZ; Ren XC; Zhang Y; Chen CS; Ye YC; Yang JM; Cheng Y
Theranostics; 2020; 10(4):1833-1848. PubMed ID: 32042339
[No Abstract] [Full Text] [Related]
60. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
Kondo N; Toyama T; Sugiura H; Fujii Y; Yamashita H
Cancer Res; 2008 Jul; 68(13):5004-8. PubMed ID: 18593897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
